Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Centessa Pharmaceuticals (CNTA)

Annual Return

Over the past 3 years, CNTA has had an average annual return of +79.71%, outperforming the benchmark SPY, which returned +19.37% annual.

Over the past 5 years, CNTA has had an average annual return of +14.26%, outperforming the benchmark SPY, which returned +12.72% annual.

Since May 28, 2021, CNTA has had an average annual return of +13.02%, underperforming the benchmark SPY, which returned +13.20% annual.

202620252024202320222021
+61.94%+49.32%+110.41%+156.84%-72.47%-48.23%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-1.76%+9.31%+47.88%-0.76%+0.86%+1.87%+61.94%
2025+1.01%-8.10%-7.53%-4.66%-1.46%-2.74%+30.67%-2.20%+44.42%+2.68%+16.59%-13.85%+49.32%
2024+2.90%+28.31%+7.51%-18.94%-5.77%+4.64%+16.59%+28.22%+18.45%-5.94%+19.07%-6.47%+110.41%
2023+29.05%-12.02%+9.39%+22.60%-4.42%+37.22%+27.62%-4.54%-14.19%+1.55%-8.67%+32.66%+156.84%
2022-15.36%-6.41%+0.56%-2.79%-48.39%+8.22%-11.30%+0.70%-7.60%-1.24%+0.77%-22.51%-72.47%
2021+0%+2.11%-7.06%+6.83%-24.27%+3%-31.11%-4.97%-48.23%

Drawdown analysis of Centessa Pharmaceuticals (CNTA)

The maximum drawdown for the CNTA was -88.19%, occurring on Feb 16, 2023. Recovery took 687 trading sessions.

Since May 28, 2021 CNTA has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 2 times
  • 10% or more: 3 times
DepthStartTo BottomBottomTo RecoverEndTotal
-88.19%Jun 17, 2021420Feb 16, 2023687Nov 12, 20251107
-26.38%Dec 5, 202524Jan 12, 202654Mar 31, 202678
-13.54%Jun 2, 20217Jun 11, 20214Jun 17, 202111
-3.06%Nov 24, 20254Dec 1, 20253Dec 4, 20257
-2.89%Nov 18, 20252Nov 20, 20252Nov 24, 20254
-2.74%Nov 12, 20251Nov 13, 20251Nov 14, 20252
-1.10%Apr 1, 202620Apr 30, 202622Jun 2, 202642
-1.05%Nov 14, 20251Nov 17, 20251Nov 18, 20252
-0.70%Jun 2, 20263Jun 5, 20269Jun 18, 202612